Global Biohacking
Global Biohacking

Biohacking Comprehensive Study by Type (Digital Health, Nutrition, Fitness, Meditation, Pharmaceuticals), Application (Synthetic Biology, Genetic Engineering, Forensic Sciences, Others), Industry Verticals (Biotechnology Industry, Pharmaceutical Industry, Research Industry, Others), Device (Smart Drugs, Microchips, Magnetic Fingertips, Strains, Others) Players and Region - Global Market Outlook to 2025

Biohacking Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Mar 2020 Edition 218 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Biohacking which is also known as do-it-yourself biology science is an extremely broad and amorphous term that covers a huge range of activities. From performing the science experiments on yeast to the tracking of one's own sleep and diet for changing their own biology of the body by pumping a younger person's blood into the other person's blood veins in order to aging (young blood transfusion). The biohacking involves merging body modification with technology. Biohackers are involved in open source biology asserting who performs the art of changing the environment inside or outside the human body to hold control over its upgrading mind.

The market study is being classified by Type (Digital Health, Nutrition, Fitness, Meditation and Pharmaceuticals), by Application (Synthetic Biology, Genetic Engineering, Forensic Sciences and Others) and major geographies with country level break-up.

uBiome (United States), Soylent Nutrition, Inc. (United States), Fitbit, Inc. (United States), Neuralink Corporation (United States), Nootrobox (HVMN) (United States), Thync Global Inc. (United States), Synbiota (Canada), DNA Fit (United Kingdom), The ODIN (United States) and Behavioural Technology Inc. (Pavlok) (United States) are some of the key players profiled in the study.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Biohacking market by Type, Application and Region.

On the basis of geography, the market of Biohacking has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Demand for Digital Health and Fitness
  • Awareness about Mental and Physical Health

Market Trend
  • The Advent of Microchips, Sensors and Other Wearables to Regulate the Sleep and Other Health Patterns
  • Increasing Consumption of Nutriritand Healthy Food and Supplements for Biohacking

Restraints
  • Safety Risks Associated with Biohacking
  • Stringent Regulatory Compliances with Biohacking

Opportunities
  • Availability of Biohacking Supplements Online will Boos the Market
  • High Potential Innovations in Biohacking

Challenges
  • Expensive Biohacking Devices


On 23rd April 2019, DNA Fit launched the new Health Fit test, featuring most in-depth reports yet on sleep and stress genetics alongside diet and fitness insights. This test explores the number of genetic factors that can affect wellbeings such as sleep quality and the personal impact of caffeine on sleep. Analyzing six specific genes that combine to generate the customer’s ‘chronotype’, this assesses whether a person is genetically predisposed to heighten hormonal activity in the morning or evening.
"The U.S. Food and Drug Administration (FDA), for example, has extensive power to regulate the public health impacts of genetic biohacking, with jurisdiction that reaches farther than many biohackers realize. In many circumstances, the things used by genetic biohackers—such as raw biological materials, traditional drug products, and DIY CRISPR kits—are, by statute, FDA-regulatable drugs."

Key Target Audience
Biohacking Device Manufacturers, Research and Development Institutes, National Laboratories, Financial Institutes and Venture Capital, Regulatory Bodies and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Digital Health
  • Nutrition
  • Fitness
  • Meditation
  • Pharmaceuticals
By Application
  • Synthetic Biology
  • Genetic Engineering
  • Forensic Sciences
  • Others
By Industry Verticals
  • Biotechnology Industry
  • Pharmaceutical Industry
  • Research Industry
  • Others

By Device
  • Smart Drugs
  • Microchips
  • Magnetic Fingertips
  • Strains
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Demand for Digital Health and Fitness
      • 3.2.2. Awareness about Mental and Physical Health
    • 3.3. Market Challenges
      • 3.3.1. Expensive Biohacking Devices
    • 3.4. Market Trends
      • 3.4.1. The Advent of Microchips, Sensors and Other Wearables to Regulate the Sleep and Other Health Patterns
      • 3.4.2. Increasing Consumption of Nutriritand Healthy Food and Supplements for Biohacking
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biohacking, by Type, Application, Industry Verticals, Device and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Biohacking (Value)
      • 5.2.1. Global Biohacking by: Type (Value)
        • 5.2.1.1. Digital Health
        • 5.2.1.2. Nutrition
        • 5.2.1.3. Fitness
        • 5.2.1.4. Meditation
        • 5.2.1.5. Pharmaceuticals
      • 5.2.2. Global Biohacking by: Application (Value)
        • 5.2.2.1. Synthetic Biology
        • 5.2.2.2. Genetic Engineering
        • 5.2.2.3. Forensic Sciences
        • 5.2.2.4. Others
      • 5.2.3. Global Biohacking by: Industry Verticals (Value)
        • 5.2.3.1. Biotechnology Industry
        • 5.2.3.2. Pharmaceutical Industry
        • 5.2.3.3. Research Industry
        • 5.2.3.4. Others
      • 5.2.4. Global Biohacking by: Device (Value)
        • 5.2.4.1. Smart Drugs
        • 5.2.4.2. Microchips
        • 5.2.4.3. Magnetic Fingertips
        • 5.2.4.4. Strains
        • 5.2.4.5. Others
      • 5.2.5. Global Biohacking Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Biohacking: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. UBiome (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Soylent Nutrition, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Fitbit, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Neuralink Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nootrobox (HVMN) (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Thync Global Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Synbiota (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DNA Fit (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The ODIN (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Behavioural Technology Inc. (Pavlok) (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biohacking Sale, by Type, Application, Industry Verticals, Device and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Biohacking (Value)
      • 7.2.1. Global Biohacking by: Type (Value)
        • 7.2.1.1. Digital Health
        • 7.2.1.2. Nutrition
        • 7.2.1.3. Fitness
        • 7.2.1.4. Meditation
        • 7.2.1.5. Pharmaceuticals
      • 7.2.2. Global Biohacking by: Application (Value)
        • 7.2.2.1. Synthetic Biology
        • 7.2.2.2. Genetic Engineering
        • 7.2.2.3. Forensic Sciences
        • 7.2.2.4. Others
      • 7.2.3. Global Biohacking by: Industry Verticals (Value)
        • 7.2.3.1. Biotechnology Industry
        • 7.2.3.2. Pharmaceutical Industry
        • 7.2.3.3. Research Industry
        • 7.2.3.4. Others
      • 7.2.4. Global Biohacking by: Device (Value)
        • 7.2.4.1. Smart Drugs
        • 7.2.4.2. Microchips
        • 7.2.4.3. Magnetic Fingertips
        • 7.2.4.4. Strains
        • 7.2.4.5. Others
      • 7.2.5. Global Biohacking Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biohacking: by Type(USD Million)
  • Table 2. Biohacking Digital Health , by Region USD Million (2014-2019)
  • Table 3. Biohacking Nutrition , by Region USD Million (2014-2019)
  • Table 4. Biohacking Fitness , by Region USD Million (2014-2019)
  • Table 5. Biohacking Meditation , by Region USD Million (2014-2019)
  • Table 6. Biohacking Pharmaceuticals , by Region USD Million (2014-2019)
  • Table 7. Biohacking: by Application(USD Million)
  • Table 8. Biohacking Synthetic Biology , by Region USD Million (2014-2019)
  • Table 9. Biohacking Genetic Engineering , by Region USD Million (2014-2019)
  • Table 10. Biohacking Forensic Sciences , by Region USD Million (2014-2019)
  • Table 11. Biohacking Others , by Region USD Million (2014-2019)
  • Table 12. Biohacking: by Industry Verticals(USD Million)
  • Table 13. Biohacking Biotechnology Industry , by Region USD Million (2014-2019)
  • Table 14. Biohacking Pharmaceutical Industry , by Region USD Million (2014-2019)
  • Table 15. Biohacking Research Industry , by Region USD Million (2014-2019)
  • Table 16. Biohacking Others , by Region USD Million (2014-2019)
  • Table 17. Biohacking: by Device(USD Million)
  • Table 18. Biohacking Smart Drugs , by Region USD Million (2014-2019)
  • Table 19. Biohacking Microchips , by Region USD Million (2014-2019)
  • Table 20. Biohacking Magnetic Fingertips , by Region USD Million (2014-2019)
  • Table 21. Biohacking Strains , by Region USD Million (2014-2019)
  • Table 22. Biohacking Others , by Region USD Million (2014-2019)
  • Table 23. South America Biohacking, by Country USD Million (2014-2019)
  • Table 24. South America Biohacking, by Type USD Million (2014-2019)
  • Table 25. South America Biohacking, by Application USD Million (2014-2019)
  • Table 26. South America Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 27. South America Biohacking, by Device USD Million (2014-2019)
  • Table 28. Brazil Biohacking, by Type USD Million (2014-2019)
  • Table 29. Brazil Biohacking, by Application USD Million (2014-2019)
  • Table 30. Brazil Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 31. Brazil Biohacking, by Device USD Million (2014-2019)
  • Table 32. Argentina Biohacking, by Type USD Million (2014-2019)
  • Table 33. Argentina Biohacking, by Application USD Million (2014-2019)
  • Table 34. Argentina Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 35. Argentina Biohacking, by Device USD Million (2014-2019)
  • Table 36. Rest of South America Biohacking, by Type USD Million (2014-2019)
  • Table 37. Rest of South America Biohacking, by Application USD Million (2014-2019)
  • Table 38. Rest of South America Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 39. Rest of South America Biohacking, by Device USD Million (2014-2019)
  • Table 40. Asia Pacific Biohacking, by Country USD Million (2014-2019)
  • Table 41. Asia Pacific Biohacking, by Type USD Million (2014-2019)
  • Table 42. Asia Pacific Biohacking, by Application USD Million (2014-2019)
  • Table 43. Asia Pacific Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 44. Asia Pacific Biohacking, by Device USD Million (2014-2019)
  • Table 45. China Biohacking, by Type USD Million (2014-2019)
  • Table 46. China Biohacking, by Application USD Million (2014-2019)
  • Table 47. China Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 48. China Biohacking, by Device USD Million (2014-2019)
  • Table 49. Japan Biohacking, by Type USD Million (2014-2019)
  • Table 50. Japan Biohacking, by Application USD Million (2014-2019)
  • Table 51. Japan Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 52. Japan Biohacking, by Device USD Million (2014-2019)
  • Table 53. India Biohacking, by Type USD Million (2014-2019)
  • Table 54. India Biohacking, by Application USD Million (2014-2019)
  • Table 55. India Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 56. India Biohacking, by Device USD Million (2014-2019)
  • Table 57. South Korea Biohacking, by Type USD Million (2014-2019)
  • Table 58. South Korea Biohacking, by Application USD Million (2014-2019)
  • Table 59. South Korea Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 60. South Korea Biohacking, by Device USD Million (2014-2019)
  • Table 61. Taiwan Biohacking, by Type USD Million (2014-2019)
  • Table 62. Taiwan Biohacking, by Application USD Million (2014-2019)
  • Table 63. Taiwan Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 64. Taiwan Biohacking, by Device USD Million (2014-2019)
  • Table 65. Australia Biohacking, by Type USD Million (2014-2019)
  • Table 66. Australia Biohacking, by Application USD Million (2014-2019)
  • Table 67. Australia Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 68. Australia Biohacking, by Device USD Million (2014-2019)
  • Table 69. Rest of Asia-Pacific Biohacking, by Type USD Million (2014-2019)
  • Table 70. Rest of Asia-Pacific Biohacking, by Application USD Million (2014-2019)
  • Table 71. Rest of Asia-Pacific Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 72. Rest of Asia-Pacific Biohacking, by Device USD Million (2014-2019)
  • Table 73. Europe Biohacking, by Country USD Million (2014-2019)
  • Table 74. Europe Biohacking, by Type USD Million (2014-2019)
  • Table 75. Europe Biohacking, by Application USD Million (2014-2019)
  • Table 76. Europe Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 77. Europe Biohacking, by Device USD Million (2014-2019)
  • Table 78. Germany Biohacking, by Type USD Million (2014-2019)
  • Table 79. Germany Biohacking, by Application USD Million (2014-2019)
  • Table 80. Germany Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 81. Germany Biohacking, by Device USD Million (2014-2019)
  • Table 82. France Biohacking, by Type USD Million (2014-2019)
  • Table 83. France Biohacking, by Application USD Million (2014-2019)
  • Table 84. France Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 85. France Biohacking, by Device USD Million (2014-2019)
  • Table 86. Italy Biohacking, by Type USD Million (2014-2019)
  • Table 87. Italy Biohacking, by Application USD Million (2014-2019)
  • Table 88. Italy Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 89. Italy Biohacking, by Device USD Million (2014-2019)
  • Table 90. United Kingdom Biohacking, by Type USD Million (2014-2019)
  • Table 91. United Kingdom Biohacking, by Application USD Million (2014-2019)
  • Table 92. United Kingdom Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 93. United Kingdom Biohacking, by Device USD Million (2014-2019)
  • Table 94. Netherlands Biohacking, by Type USD Million (2014-2019)
  • Table 95. Netherlands Biohacking, by Application USD Million (2014-2019)
  • Table 96. Netherlands Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 97. Netherlands Biohacking, by Device USD Million (2014-2019)
  • Table 98. Rest of Europe Biohacking, by Type USD Million (2014-2019)
  • Table 99. Rest of Europe Biohacking, by Application USD Million (2014-2019)
  • Table 100. Rest of Europe Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 101. Rest of Europe Biohacking, by Device USD Million (2014-2019)
  • Table 102. MEA Biohacking, by Country USD Million (2014-2019)
  • Table 103. MEA Biohacking, by Type USD Million (2014-2019)
  • Table 104. MEA Biohacking, by Application USD Million (2014-2019)
  • Table 105. MEA Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 106. MEA Biohacking, by Device USD Million (2014-2019)
  • Table 107. Middle East Biohacking, by Type USD Million (2014-2019)
  • Table 108. Middle East Biohacking, by Application USD Million (2014-2019)
  • Table 109. Middle East Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 110. Middle East Biohacking, by Device USD Million (2014-2019)
  • Table 111. Africa Biohacking, by Type USD Million (2014-2019)
  • Table 112. Africa Biohacking, by Application USD Million (2014-2019)
  • Table 113. Africa Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 114. Africa Biohacking, by Device USD Million (2014-2019)
  • Table 115. North America Biohacking, by Country USD Million (2014-2019)
  • Table 116. North America Biohacking, by Type USD Million (2014-2019)
  • Table 117. North America Biohacking, by Application USD Million (2014-2019)
  • Table 118. North America Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 119. North America Biohacking, by Device USD Million (2014-2019)
  • Table 120. United States Biohacking, by Type USD Million (2014-2019)
  • Table 121. United States Biohacking, by Application USD Million (2014-2019)
  • Table 122. United States Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 123. United States Biohacking, by Device USD Million (2014-2019)
  • Table 124. Canada Biohacking, by Type USD Million (2014-2019)
  • Table 125. Canada Biohacking, by Application USD Million (2014-2019)
  • Table 126. Canada Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 127. Canada Biohacking, by Device USD Million (2014-2019)
  • Table 128. Mexico Biohacking, by Type USD Million (2014-2019)
  • Table 129. Mexico Biohacking, by Application USD Million (2014-2019)
  • Table 130. Mexico Biohacking, by Industry Verticals USD Million (2014-2019)
  • Table 131. Mexico Biohacking, by Device USD Million (2014-2019)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Biohacking: by Type(USD Million)
  • Table 143. Biohacking Digital Health , by Region USD Million (2020-2025)
  • Table 144. Biohacking Nutrition , by Region USD Million (2020-2025)
  • Table 145. Biohacking Fitness , by Region USD Million (2020-2025)
  • Table 146. Biohacking Meditation , by Region USD Million (2020-2025)
  • Table 147. Biohacking Pharmaceuticals , by Region USD Million (2020-2025)
  • Table 148. Biohacking: by Application(USD Million)
  • Table 149. Biohacking Synthetic Biology , by Region USD Million (2020-2025)
  • Table 150. Biohacking Genetic Engineering , by Region USD Million (2020-2025)
  • Table 151. Biohacking Forensic Sciences , by Region USD Million (2020-2025)
  • Table 152. Biohacking Others , by Region USD Million (2020-2025)
  • Table 153. Biohacking: by Industry Verticals(USD Million)
  • Table 154. Biohacking Biotechnology Industry , by Region USD Million (2020-2025)
  • Table 155. Biohacking Pharmaceutical Industry , by Region USD Million (2020-2025)
  • Table 156. Biohacking Research Industry , by Region USD Million (2020-2025)
  • Table 157. Biohacking Others , by Region USD Million (2020-2025)
  • Table 158. Biohacking: by Device(USD Million)
  • Table 159. Biohacking Smart Drugs , by Region USD Million (2020-2025)
  • Table 160. Biohacking Microchips , by Region USD Million (2020-2025)
  • Table 161. Biohacking Magnetic Fingertips , by Region USD Million (2020-2025)
  • Table 162. Biohacking Strains , by Region USD Million (2020-2025)
  • Table 163. Biohacking Others , by Region USD Million (2020-2025)
  • Table 164. South America Biohacking, by Country USD Million (2020-2025)
  • Table 165. South America Biohacking, by Type USD Million (2020-2025)
  • Table 166. South America Biohacking, by Application USD Million (2020-2025)
  • Table 167. South America Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 168. South America Biohacking, by Device USD Million (2020-2025)
  • Table 169. Brazil Biohacking, by Type USD Million (2020-2025)
  • Table 170. Brazil Biohacking, by Application USD Million (2020-2025)
  • Table 171. Brazil Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 172. Brazil Biohacking, by Device USD Million (2020-2025)
  • Table 173. Argentina Biohacking, by Type USD Million (2020-2025)
  • Table 174. Argentina Biohacking, by Application USD Million (2020-2025)
  • Table 175. Argentina Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 176. Argentina Biohacking, by Device USD Million (2020-2025)
  • Table 177. Rest of South America Biohacking, by Type USD Million (2020-2025)
  • Table 178. Rest of South America Biohacking, by Application USD Million (2020-2025)
  • Table 179. Rest of South America Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 180. Rest of South America Biohacking, by Device USD Million (2020-2025)
  • Table 181. Asia Pacific Biohacking, by Country USD Million (2020-2025)
  • Table 182. Asia Pacific Biohacking, by Type USD Million (2020-2025)
  • Table 183. Asia Pacific Biohacking, by Application USD Million (2020-2025)
  • Table 184. Asia Pacific Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 185. Asia Pacific Biohacking, by Device USD Million (2020-2025)
  • Table 186. China Biohacking, by Type USD Million (2020-2025)
  • Table 187. China Biohacking, by Application USD Million (2020-2025)
  • Table 188. China Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 189. China Biohacking, by Device USD Million (2020-2025)
  • Table 190. Japan Biohacking, by Type USD Million (2020-2025)
  • Table 191. Japan Biohacking, by Application USD Million (2020-2025)
  • Table 192. Japan Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 193. Japan Biohacking, by Device USD Million (2020-2025)
  • Table 194. India Biohacking, by Type USD Million (2020-2025)
  • Table 195. India Biohacking, by Application USD Million (2020-2025)
  • Table 196. India Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 197. India Biohacking, by Device USD Million (2020-2025)
  • Table 198. South Korea Biohacking, by Type USD Million (2020-2025)
  • Table 199. South Korea Biohacking, by Application USD Million (2020-2025)
  • Table 200. South Korea Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 201. South Korea Biohacking, by Device USD Million (2020-2025)
  • Table 202. Taiwan Biohacking, by Type USD Million (2020-2025)
  • Table 203. Taiwan Biohacking, by Application USD Million (2020-2025)
  • Table 204. Taiwan Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 205. Taiwan Biohacking, by Device USD Million (2020-2025)
  • Table 206. Australia Biohacking, by Type USD Million (2020-2025)
  • Table 207. Australia Biohacking, by Application USD Million (2020-2025)
  • Table 208. Australia Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 209. Australia Biohacking, by Device USD Million (2020-2025)
  • Table 210. Rest of Asia-Pacific Biohacking, by Type USD Million (2020-2025)
  • Table 211. Rest of Asia-Pacific Biohacking, by Application USD Million (2020-2025)
  • Table 212. Rest of Asia-Pacific Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 213. Rest of Asia-Pacific Biohacking, by Device USD Million (2020-2025)
  • Table 214. Europe Biohacking, by Country USD Million (2020-2025)
  • Table 215. Europe Biohacking, by Type USD Million (2020-2025)
  • Table 216. Europe Biohacking, by Application USD Million (2020-2025)
  • Table 217. Europe Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 218. Europe Biohacking, by Device USD Million (2020-2025)
  • Table 219. Germany Biohacking, by Type USD Million (2020-2025)
  • Table 220. Germany Biohacking, by Application USD Million (2020-2025)
  • Table 221. Germany Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 222. Germany Biohacking, by Device USD Million (2020-2025)
  • Table 223. France Biohacking, by Type USD Million (2020-2025)
  • Table 224. France Biohacking, by Application USD Million (2020-2025)
  • Table 225. France Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 226. France Biohacking, by Device USD Million (2020-2025)
  • Table 227. Italy Biohacking, by Type USD Million (2020-2025)
  • Table 228. Italy Biohacking, by Application USD Million (2020-2025)
  • Table 229. Italy Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 230. Italy Biohacking, by Device USD Million (2020-2025)
  • Table 231. United Kingdom Biohacking, by Type USD Million (2020-2025)
  • Table 232. United Kingdom Biohacking, by Application USD Million (2020-2025)
  • Table 233. United Kingdom Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 234. United Kingdom Biohacking, by Device USD Million (2020-2025)
  • Table 235. Netherlands Biohacking, by Type USD Million (2020-2025)
  • Table 236. Netherlands Biohacking, by Application USD Million (2020-2025)
  • Table 237. Netherlands Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 238. Netherlands Biohacking, by Device USD Million (2020-2025)
  • Table 239. Rest of Europe Biohacking, by Type USD Million (2020-2025)
  • Table 240. Rest of Europe Biohacking, by Application USD Million (2020-2025)
  • Table 241. Rest of Europe Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 242. Rest of Europe Biohacking, by Device USD Million (2020-2025)
  • Table 243. MEA Biohacking, by Country USD Million (2020-2025)
  • Table 244. MEA Biohacking, by Type USD Million (2020-2025)
  • Table 245. MEA Biohacking, by Application USD Million (2020-2025)
  • Table 246. MEA Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 247. MEA Biohacking, by Device USD Million (2020-2025)
  • Table 248. Middle East Biohacking, by Type USD Million (2020-2025)
  • Table 249. Middle East Biohacking, by Application USD Million (2020-2025)
  • Table 250. Middle East Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 251. Middle East Biohacking, by Device USD Million (2020-2025)
  • Table 252. Africa Biohacking, by Type USD Million (2020-2025)
  • Table 253. Africa Biohacking, by Application USD Million (2020-2025)
  • Table 254. Africa Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 255. Africa Biohacking, by Device USD Million (2020-2025)
  • Table 256. North America Biohacking, by Country USD Million (2020-2025)
  • Table 257. North America Biohacking, by Type USD Million (2020-2025)
  • Table 258. North America Biohacking, by Application USD Million (2020-2025)
  • Table 259. North America Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 260. North America Biohacking, by Device USD Million (2020-2025)
  • Table 261. United States Biohacking, by Type USD Million (2020-2025)
  • Table 262. United States Biohacking, by Application USD Million (2020-2025)
  • Table 263. United States Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 264. United States Biohacking, by Device USD Million (2020-2025)
  • Table 265. Canada Biohacking, by Type USD Million (2020-2025)
  • Table 266. Canada Biohacking, by Application USD Million (2020-2025)
  • Table 267. Canada Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 268. Canada Biohacking, by Device USD Million (2020-2025)
  • Table 269. Mexico Biohacking, by Type USD Million (2020-2025)
  • Table 270. Mexico Biohacking, by Application USD Million (2020-2025)
  • Table 271. Mexico Biohacking, by Industry Verticals USD Million (2020-2025)
  • Table 272. Mexico Biohacking, by Device USD Million (2020-2025)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biohacking: by Type USD Million (2014-2019)
  • Figure 5. Global Biohacking: by Application USD Million (2014-2019)
  • Figure 6. Global Biohacking: by Industry Verticals USD Million (2014-2019)
  • Figure 7. Global Biohacking: by Device USD Million (2014-2019)
  • Figure 8. South America Biohacking Share (%), by Country
  • Figure 9. Asia Pacific Biohacking Share (%), by Country
  • Figure 10. Europe Biohacking Share (%), by Country
  • Figure 11. MEA Biohacking Share (%), by Country
  • Figure 12. North America Biohacking Share (%), by Country
  • Figure 13. Global Biohacking share by Players 2019 (%)
  • Figure 14. Global Biohacking share by Players (Top 3) 2019(%)
  • Figure 15. Global Biohacking share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. UBiome (United States) Revenue, Net Income and Gross profit
  • Figure 18. UBiome (United States) Revenue: by Geography 2019
  • Figure 19. Soylent Nutrition, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Soylent Nutrition, Inc. (United States) Revenue: by Geography 2019
  • Figure 21. Fitbit, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Fitbit, Inc. (United States) Revenue: by Geography 2019
  • Figure 23. Neuralink Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Neuralink Corporation (United States) Revenue: by Geography 2019
  • Figure 25. Nootrobox (HVMN) (United States) Revenue, Net Income and Gross profit
  • Figure 26. Nootrobox (HVMN) (United States) Revenue: by Geography 2019
  • Figure 27. Thync Global Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Thync Global Inc. (United States) Revenue: by Geography 2019
  • Figure 29. Synbiota (Canada) Revenue, Net Income and Gross profit
  • Figure 30. Synbiota (Canada) Revenue: by Geography 2019
  • Figure 31. DNA Fit (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. DNA Fit (United Kingdom) Revenue: by Geography 2019
  • Figure 33. The ODIN (United States) Revenue, Net Income and Gross profit
  • Figure 34. The ODIN (United States) Revenue: by Geography 2019
  • Figure 35. Behavioural Technology Inc. (Pavlok) (United States) Revenue, Net Income and Gross profit
  • Figure 36. Behavioural Technology Inc. (Pavlok) (United States) Revenue: by Geography 2019
  • Figure 37. Global Biohacking: by Type USD Million (2020-2025)
  • Figure 38. Global Biohacking: by Application USD Million (2020-2025)
  • Figure 39. Global Biohacking: by Industry Verticals USD Million (2020-2025)
  • Figure 40. Global Biohacking: by Device USD Million (2020-2025)
  • Figure 41. South America Biohacking Share (%), by Country
  • Figure 42. Asia Pacific Biohacking Share (%), by Country
  • Figure 43. Europe Biohacking Share (%), by Country
  • Figure 44. MEA Biohacking Share (%), by Country
  • Figure 45. North America Biohacking Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • uBiome (United States)
  • Soylent Nutrition, Inc. (United States)
  • Fitbit, Inc. (United States)
  • Neuralink Corporation (United States)
  • Nootrobox (HVMN) (United States)
  • Thync Global Inc. (United States)
  • Synbiota (Canada)
  • DNA Fit (United Kingdom)
  • The ODIN (United States)
  • Behavioural Technology Inc. (Pavlok) (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation